Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by dardanion Jul 23, 2016 8:45am
176 Views
Post# 25078136

RE:RE:One thing is a fact

RE:RE:One thing is a factThe most likely reason for rescheduling of Roger's interview is that the company will issue an official news release to the market next week on the status of the ITA. It's about due having missed on the June guidance and now it appears the July guidance. Investors need to be brought up to date but it is not appropriate to do that through a vehicle like the Korelin show. Whether the ITA is a go or it will be further delayed has to come by way of a news release so all investors get material news at the same time. Those are the rules. Not everyone listens to the Korelin show and since the moderators are also TLT shareholders there could be suspicions raised whether they got a tip since the show is scripted. I could be wrong, rare but it happens, but it looks like a news release first with Roger following that up with an appearance on the show to offer further details or excuses to investors. As to the content of the NR all we have so far is a hint that Roger was going to speak to the progress of the ITA which in plain English means they're still working  on it.
Bullboard Posts